Journal of the Korean Society of Food Science and Nutrition (한국식품영양과학회지)

The Korean Society of Food Science and Nutrition (한국식품영양과학회)
권호 표지
DOI QR코드

DOI QR Code

Vitamin D and Depression

비타민 D와 우울증

  • Cho, Su Kyung (Department of Food and Nutrition, Yeungnam University) ;
  • Koo, Sle (Department of Food and Nutrition, Yeungnam University) ;
  • Park, Kyong (Department of Food and Nutrition, Yeungnam University)
  • 조수경 (영남대학교 식품영양학과) ;
  • 구슬 (영남대학교 식품영양학과) ;
  • 박경 (영남대학교 식품영양학과)
  • Received : 2014.06.20
  • Accepted : 2014.08.14
  • Published : 2014.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

Recent studies have shown that insufficient or deficient vitamin D status may be linked to increased risk of depressive conditions or depression. The aim of this study was to review all available evidence on vitamin D, depression, and any association between them. Cross-sectional, case-control, and cohort studies have reported contradictory results. Some have reported that low levels of vitamin D may be associated with higher risk of depression or depressive symptoms while others reported that vitamin D status may not be related to depression. Recent clinical trials examining the effects of vitamin D supplementation on depression have also showed discrepant results. However, meta-analysis study results are consistent regarding the beneficial effects of vitamin D. Several mechanisms that account for these beneficial effects of vitamin D on depression have been reported but remain largely speculative. Vitamin D deficiency is very common, and prevalence of depression is increasing in the Asian population, especially females. However, limited literature is available on this population. Considering research results of a potential inverse association between vitamin D level and prevalence of depression, it is important to advance our understanding of the role of vitamin D in depression and conduct well-designed prospective trials in the Asian population.

본 연구에서는 비타민 D와 정신질환, 특히 전 세계적으로 높은 유병률 추이를 보이고 있는 우울증과의 연관성을 살펴보기 위해 비타민 D의 종류, 급원 식품, 비타민 D 영양상태 현황 및 이에 영향을 미치는 요인, 비타민 D와 우울증과의 연관성에 대한 국내외 문헌을 체계적으로 고찰하여 요약하였다. 그 결과 첫째, 비타민 D는 자연계에 주로 비타민 $D_2$(ergocalciferol)와 $D_3$(cholecalciferol) 두 가지 형태로 존재하며 주로 대구간유, 고등어, 정어리와 같은 지방이 많은 생선, 난황, 표고버섯 등이 주요 급원 식품이다. 둘째, 국내 외 다양한 인구 집단을 대상으로 비타민 D 수준을 고찰한 결과 비타민 D 결핍은 매우 높은 수준을 보이고 있다. 특히 한국인의 청소년을 대상으로 한 연구 결과 혈청 25(OH)D 20 ng/mL 미만인 남녀는 각각 89%, 99%로 매우 낮은 비타민 D 수준을 보였다. 셋째, 체내 비타민 D의 수준에 영향을 미칠 수 있는 요인으로는 인종, 거주 지역, 위도, 의복차림, 계절적 차이, 직업, 자외선 노출 정도, 보충제 복용 여부 등이 보고되었으며, 일반적으로 연령의 증가(한국인 및 일본인의 경우 반대 방향), 자외선 차단제의 사용, 어두운 피부색, 흡수 불량 및 비만은 비타민 D의 합성, 흡수 및 이용률에 영향을 주어 비타민 D 부족증의 원인이 될 수 있다고 보고되었다. 넷째, 최근 비타민 D 수준과 우울증과의 연관성을 분석한 국외 역학연구들은 꾸준히 보고되고 있으며 이에 대한 횡단 연구와 코호트 연구 결과는 불일치한 양상을 보이고 있다. 또한 최근 비타민 D 보충과의 관계를 규명하기 위해 임상시험연구도 일부 진행되었으나 이 또한 불일치한 결과를 보였지만 보충제로 얻는 비타민 D는 식이로부터 얻는 비타민 D와 다르다는 가능성을 제시하고 있다. 더 나아가 횡단 연구 및 코호트 연구를 메타 분석한 연구 결과 우울증에 대한 비타민 D의 이로운 효과에 대하여 비교적 일치하는 연구 결과를 제시하고 있다. 그러나 대부분의 연구 결과는 국외에서 진행된 연구이며 한국인을 대상으로 분석된 연구는 매우 제한적이다. 따라서 한국인을 대상으로 한 후속 연구가 요구된다.

Keywords

References

  1. Korean Association for Vitamin Research. 2009. Vitamin D. Hansol Medical Book, Seoul, Korea. p 14-94.
  2. Hadley ME, Levine JE. 2008. Endocrinology. Pearson Education Korea Ltd. and Bio Science, Seoul, Korea. p 189-219.
  3. Koeppen BM, Stanton BA. 2009. Berne & Levy Physiology. 6th ed. E-public, Seoul, Korea. p 645-798.
  4. Holick MF. 2006. Resurrection of vitamin D deficiency and rickets. J Clin Invest 116: 2062-2072. https://doi.org/10.1172/JCI29449
  5. Ford ES, Ajani UA, McGuire LC, Liu S. 2005. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 28: 1228-1230. https://doi.org/10.2337/diacare.28.5.1228
  6. Mitri J, Muraru MD, Pittas AG. 2011. Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr 65: 1005-1015. https://doi.org/10.1038/ejcn.2011.118
  7. Sun Q, Shi L, Rimm EB, Giovannucci EL, Hu FB, Manson JE, Rexrode KM. 2011. Vitamin D intake and risk of cardiovascular disease in US men and women. Am J Clin Nutr 94: 534-542. https://doi.org/10.3945/ajcn.110.008763
  8. Giovannucci E. 2009. Vitamin D and cancer incidence in the Harvard cohorts. Ann Epidemiol 19: 84-88. https://doi.org/10.1016/j.annepidem.2007.12.002
  9. Stewart R, Hirani V. 2010. Relationship between vitamin D levels and depressive symptoms in older residents from a national survey population. Psychosom Med 72: 608-612. https://doi.org/10.1097/PSY.0b013e3181e9bf15
  10. May HT, Bair TL, Lappe DL, Anderson JL, Horne BD, Carlquist JF, Muhlestein JB. 2010. Association of vitamin D levels with incident depression among a general cardiovascular population. Am Heart J 159: 1037-1043. https://doi.org/10.1016/j.ahj.2010.03.017
  11. Milaneschi Y, Shardell M, Corsi AM, Vazzana R, Bandinelli S, Guralnik JM, Ferrucci L. 2010. Serum 25-hydroxyvitamin D and depressive symptoms in older women and men. J Clin Endocrinol Metab 95: 3225-3233. https://doi.org/10.1210/jc.2010-0347
  12. Ganji V, Milone C, Cody MM, McCarty F, Wang YT. 2010. Serum vitamin D concentrations are related to depression in young adult US population: the Third National Health and Nutrition Examination Survey. Int Arch Med 3: 29. https://doi.org/10.1186/1755-7682-3-29
  13. Yang S, Ha YS, Lee GS, Lee JS, Kwon HJ, Lee MH. 2011. Psychiatric-mental health nursing. 4th ed. Hyunmoon, Seoul, Korea. p 243-276.
  14. Park JH, Kim KW. 2011. A review of the epidemiology of depression in Korea. J Korean Med Assoc 54: 362-369. https://doi.org/10.5124/jkma.2011.54.4.362
  15. Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ. 2004. Global burden of depressive disorders in the year 2000. Br J Psychiatry 184: 386-392. https://doi.org/10.1192/bjp.184.5.386
  16. Lips P. 2006. Vitamin D physiology. Prog Biophys Mol Biol 92: 4-8. https://doi.org/10.1016/j.pbiomolbio.2006.02.016
  17. Soram Khalsa MD. 2009. The vitamin D revolution. Health Chosun, Seoul, Korea. p 23-43.
  18. Holick MF. 2007. Vitamin D deficiency. N Engl J Med 357: 266-281. https://doi.org/10.1056/NEJMra070553
  19. Muller DN, Kleinewietfeld M, Kvakan H. 2011. Vitamin D review. J Renin Angiotensin Aldosterone Syst 12: 125-128. https://doi.org/10.1177/1470320311410924
  20. Cannell JJ, Vieth R, Umhau JC, Holick MF, Grant WB, Madronich S, Garland CF, Giovannucci E. 2006. Epidemic influenza and vitamin D. Epidemiol Infect 134: 1129-1140. https://doi.org/10.1017/S0950268806007175
  21. Cannell JJ, Hollis BW. 2008. Use of vitamin D in clinical practice. Altern Med Rev 13: 6-20.
  22. Rosen CJ. 2011. Clinical practice. Vitamin D insufficiency. N Engl J Med 364: 248-254. https://doi.org/10.1056/NEJMcp1009570
  23. Zerwekh JE. 2004. The measurement of vitamin D: analytical aspects. Ann Clin Biochem 41: 272-281. https://doi.org/10.1258/0004563041201464
  24. Reichel H, Koeffler HP, Norman AW. 1989. The role of the vitamin D endocrine system in health and disease. N Engl J Med 320: 980-991. https://doi.org/10.1056/NEJM198904133201506
  25. Wei MY, Giovannucci EL. 2010. Vitamin D and multiple health outcomes in the Harvard cohorts. Mol Nutr Food Res 54: 1114-1126.
  26. Weaver CM, Fleet JC. 2004. Vitamin D requirements: current and future. Am J Clin Nutr 80: 1735-1739.
  27. Wagner D, Hanwell HE, Vieth R. 2009. An evaluation of automated methods for measurement of serum 25-hydroxyvitamin D. Clin Biochem 42: 1549-1556. https://doi.org/10.1016/j.clinbiochem.2009.07.013
  28. Hollis BW. 2008. Measuring 25-hydroxyvitamin D in a clinical environment: challenges and needs. Am J Clin Nutr 88: 507-510.
  29. Roth HJ, Schmidt-Gayk H, Weber H, Niederau C. 2008. Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography- tandem mass spectrometry as a reference. Ann Clin Biochem 45: 153-159. https://doi.org/10.1258/acb.2007.007091
  30. Ng K, Meyerhardt JA, Wu K, Feskanich D, Hollis BW, Giovannucci EL, Fuchs CS. 2008. Circulating 25-hydroxyvitamin D levels and survival in patients with colorectal cancer. J Clin Oncol 26: 2984-2991. https://doi.org/10.1200/JCO.2007.15.1027
  31. Yetley EA, Pfeiffer CM, Schleicher RL, Phinney KW, Lacher DA, Christakos S, Eckfeldt JH, Fleet JC, Howard G, Hoofnagle AN, Hui SL, Lensmeyer GL, Massaro J, Peacock M, Rosner B, Wiebe D, Bailey RL, Coates PM, Looker AC, Sempos C, Johnson CL, Picciano MF. 2010. NHANES monitoring of serum 25-hydroxyvitamin D: a roundtable summary. J Nutr 140: 2030-2045. https://doi.org/10.3945/jn.110.121483
  32. Holick MF. 2009. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol 19: 73-78. https://doi.org/10.1016/j.annepidem.2007.12.001
  33. Priemel M, von Domarus C, Klatte TO, Kessler S, Schlie J, Meier S, Proksch N, Pastor F, Netter C, Streichert T, Puschel K, AmLing M. 2010. Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res 25: 305-312. https://doi.org/10.1359/jbmr.090728
  34. Looker AC, Pfeiffer CM, Lacher DA, Schleicher RL, Picciano MF, Yetley EA. 2008. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr 88: 1519-1527. https://doi.org/10.3945/ajcn.2008.26182
  35. Looker AC, Johnson CL, Lacher DA, Pfeiffer CM, Schleicher RL, Sempos CT. 2011. Vitamin D status: United States, 2001-2006. NCHS Data Brief 59: 1-8.
  36. Greene-Finestone LS, Berger C, de Groh M, Hanley DA, Hidiroglou N, Sarafin K, Poliquin S, Krieger J, Richards JB, Goltzman D. 2011. 25-Hydroxyvitamin D in Canadian adults: biological, environmental, and behavioral correlates. Osteoporos Int 22: 1389-1399. https://doi.org/10.1007/s00198-010-1362-7
  37. Ardawi MS, Qari MH, Rouzi AA, Maimani AA, Raddadi RM. 2011. Vitamin D status in relation to obesity, bone mineral density, bone turnover markers and vitamin D receptor genotypes in healthy Saudi pre- and postmenopausal women. Osteoporos Int 22: 463-475. https://doi.org/10.1007/s00198-010-1249-7
  38. Ardawi MS, Sibiany AM, Bakhsh TM, Qari MH, Maimani AA. 2012. High prevalence of vitamin D deficiency among healthy Saudi Arabian men: relationship to bone mineral density, parathyroid hormone, bone turnover markers, and lifestyle factors. Osteoporos Int 23: 675-686. https://doi.org/10.1007/s00198-011-1606-1
  39. Choi HS, Oh HJ, Choi H, Choi WH, Kim JG, Kim KM, Kim KJ, Rhee Y, Lim SK. 2011. Vitamin D insufficiency in Korea - a greater threat to younger generation: the Korea National Health and Nutrition Examination Survey (KNHANES) 2008. J Clin Endocrinol Metab 96: 643-651. https://doi.org/10.1210/jc.2010-2133
  40. Cho SW, Kim SW, Shin CS, Kim SY. 2007. The prevalence and the threshold of vitamin D insufficiency in Korea. Korean J Bone Metab 14: 19-26.
  41. Shin YH, Kim KE, Lee C, Shin HJ, Kang MS, Lee HR, Lee YJ. 2012. High prevalence of vitamin D insufficiency or deficiency in young adolescents in Korea. Eur J Pediatr 10: 1475-1480.
  42. Nakamura K, Nashimoto M, Matsuyama S, Yamamoto M. 2001. Low serum concentrations of 25-hydroxyvitamin D in young adult Japanese women: a cross sectional study. Nutrition 17: 921-925. https://doi.org/10.1016/S0899-9007(01)00662-1
  43. McKenna MJ. 1992. Differences in vitamin D status between countries in young adults and the elderly. Am J Med 93: 69-77. https://doi.org/10.1016/0002-9343(92)90682-2
  44. Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson- Hughes B, Eisman JA, El-Hajj Fuleihan G, Josse RG, Lips P, Morales-Torres J. 2009. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 20: 1807-1820. https://doi.org/10.1007/s00198-009-0954-6
  45. Lips P. 2007. Vitamin D status and nutrition in Europe and Asia. J Steroid Biochem Mol Biol 103: 620-625. https://doi.org/10.1016/j.jsbmb.2006.12.076
  46. Aris RM, Merkel PA, Bachrach LK, Borowitz DS, Boyle MP, Elkin SL, Guise TA, Hardin DS, Haworth CS, Holick MF, Joseph PM, O'Brien K, Tullis E, Watts NB, White TB. 2005. Guide to bone health and disease in cystic fibrosis. J Clin Endocrinol Metab 90: 1888-1896. https://doi.org/10.1210/jc.2004-1629
  47. Lo CW, Paris PW, Clemens TL, Nolan J, Holick MF. 1985. Vitamin D absorption in healthy subjects and in patients with intestinal malabsorption syndromes. Am J Clin Nutr 42: 644-649.
  48. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. 2000. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72: 690-693.
  49. Peveler R, Carson A, Rodin G. 2002. Depression in medical patients. BMJ 325: 149-152. https://doi.org/10.1136/bmj.325.7356.149
  50. Mathers CD, Loncar D. 2005. Updated projections of global mortality and burden of disease, 2002-2030: data sources, methods and results. World Health Organization, Geneva, Switzerland.
  51. Mathers CD, Loncar D. 2006. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3: e442. https://doi.org/10.1371/journal.pmed.0030442
  52. Kroenke K, Spitzer RL, Williams JB. 2001. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16: 606-613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x
  53. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS. 1994. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51: 8-19. https://doi.org/10.1001/archpsyc.1994.03950010008002
  54. Kessler RC, Chiu WT, DemLer O, Merikangas KR, Walters EE. 2005. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62: 617-627. https://doi.org/10.1001/archpsyc.62.6.617
  55. Radloff LS. 1977. The CES-D scale A self-report depression scale for research in the general population. Applied Psychological Measurement 1: 385-401. https://doi.org/10.1177/014662167700100306
  56. Zigmond AS, Snaith RP. 1983. The hospital anxiety and depression scale. Acta Psychiatr Scand 67: 361-370. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x
  57. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. 1961. An inventory for measuring depression. Arch Gen Psychiatry 4: 561-571. https://doi.org/10.1001/archpsyc.1961.01710120031004
  58. Casper RC. 1998. Depression and eating disorders. Depress Anxiety 8 Suppl 1: 96-104. https://doi.org/10.1002/(SICI)1520-6394(1998)8:1+<96::AID-DA15>3.0.CO;2-4
  59. Devaud C, Jeannin A, Narring F, Ferron C, Michaud PA. 1998. Eating disorders among female adolescents in Switzerland: prevalence and associations with mental and behavioral disorders. Int J Eat Disord 24: 207-216. https://doi.org/10.1002/(SICI)1098-108X(199809)24:2<207::AID-EAT10>3.0.CO;2-W
  60. Park JE, Kim SJ, Choue RW. 2009. Study on stress, depression, binge eating, and food behavior of high school girls based on their BMI. Korean J Community Nutrition 14: 175-181.
  61. Sherwood NE, Jeffery RW, Wing RR. 1999. Binge status as a predictor of weight loss treatment outcome. Int J Obes Relat Metab Disord 23: 485-493. https://doi.org/10.1038/sj.ijo.0800846
  62. Cassidy K, Kotynia-English R, Acres J, Flicker L, Lautenschlager NT, Almeida OP. 2004. Association between lifestyle factors and mental health measures among community- dwelling older women. Aust N Z J Psychiatry 38: 940-947. https://doi.org/10.1080/j.1440-1614.2004.01485.x
  63. Pan A, Sun Q, Czernichow S, Kivimaki M, Okereke OI, Lucas M, Manson JE, Ascherio A, Hu FB. 2012. Bidirectional association between depression and obesity in middle- aged and older women. Int J Obes (Lond) 36: 595-602. https://doi.org/10.1038/ijo.2011.111
  64. Simon GE, Ludman EJ, Linde JA, Operskalski BH, Ichikawa L, Rohde P, Finch EA, Jeffery RW. 2008. Association between obesity and depression in middle-aged women. Gen Hosp Psychiatry 30: 32-39. https://doi.org/10.1016/j.genhosppsych.2007.09.001
  65. Vaccarino V, McClure C, Johnson BD, Sheps DS, Bittner V, Rutledge T, Shaw LJ, Sopko G, Olson MB, Krantz DS, Parashar S, Marroquin OC, Merz CN. 2008. Depression, the metabolic syndrome and cardiovascular risk. Psychosom Med 70: 40-48. https://doi.org/10.1097/PSY.0b013e31815c1b85
  66. Atlantis E, Shi Z, Penninx BJ, Wittert GA, Taylor A, Almeida OP. 2012. Chronic medical conditions mediate the association between depression and cardiovascular disease mortality. Soc Psychiatry Psychiatr Epidemiol 47: 615-625. https://doi.org/10.1007/s00127-011-0365-9
  67. Pan A, Lucas M, Sun Q, van Dam RM, Franco OH, Manson JE, Willett WC, Ascherio A, Hu FB. 2010. Bidirectional association between depression and type 2 diabetes mellitus in women. Arch Intern Med 170: 1884-1891.
  68. Leonard BE. 2007. Inflammation, depression and dementia: are they connected? Neurochem Res 32: 1749-1756. https://doi.org/10.1007/s11064-007-9385-y
  69. Pan A, Keum N, Okereke OI, Sun Q, Kivimaki M, Rubin RR, Hu FB. 2012. Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Diabetes Care 35: 1171-1180. https://doi.org/10.2337/dc11-2055
  70. Shim RS, Baltrus P, Ye J, Rust G. 2011. Prevalence, treatment, and control of depressive symptoms in the United States: results from the National Health and Nutrition Examination Survey (NHANES), 2005-2008. J Am Board Fam Med 24: 33-38. https://doi.org/10.3122/jabfm.2011.01.100121
  71. Pirkis J, Pfaff J, Williamson M, Tyson O, Stocks N, Goldney R, Draper B, Snowdon J, Lautenschlager N, Almeida OP. 2009. The community prevalence of depression in older Australians. J Affect Disord 115: 54-61. https://doi.org/10.1016/j.jad.2008.08.014
  72. Solhaug HI, Romuld EB, Romild U, Stordal E. 2012. Increased prevalence of depression in cohorts of the elderly: an 11-year follow-up in the general population-the HUNT study. Int Psychogeriatr 24: 151-158. https://doi.org/10.1017/S1041610211001141
  73. Roh MS, Jeon HJ, Kim H, Han SK, Hahm BJ. 2010. The prevalence and impact of depression among medical students: a nationwide cross-sectional study in South Korea. Acad Med 85: 1384-1390. https://doi.org/10.1097/ACM.0b013e3181df5e43
  74. Lee S, Tsang A, Huang YQ, He YL, Liu ZR, Zhang MY, Shen YC, Kessler RC. 2009. The epidemiology of depression in metropolitan China. Psychol Med 39: 735-747. https://doi.org/10.1017/S0033291708004091
  75. Mulsant BH, Ganguli M. 1999. Epidemiology and diagnosis of depression in late life. J Clin Psychiatry 60 Suppl 20: 9-15. https://doi.org/10.4088/JCP.v60n0104
  76. Eaton WW, Anthony JC, Tepper S, Dryman A. 1992. Psychopathology and attrition in the epidemiologic catchment area surveys. Am J Epidemiol 135: 1051-1059. https://doi.org/10.1093/oxfordjournals.aje.a116399
  77. de Graaf R, Bijl RV, Smit F, Ravelli A, Vollebergh WA. 2000. Psychiatric and sociodemographic predictors of attrition in a longitudinal study: The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Am J Epidemiol 152: 1039-1047. https://doi.org/10.1093/aje/152.11.1039
  78. Chang SM, Hahm BJ, Lee JY, Shin MS, Jeon HJ, Hong JP, Lee HB, Lee DW, Cho MJ. 2008. Cross-national difference in the prevalence of depression caused by the diagnostic threshold. J Affect Disord 106: 159-167. https://doi.org/10.1016/j.jad.2007.07.023
  79. Hoang MT, DeFina LF, Willis BL, Leonard DS, Weiner MF, Brown ES. 2011. Association between low serum 25-hydroxyvitamin D and depression in a large sample of healthy adults: The Cooper Center Longitudinal Study. Mayo Clinic Proc 86: 1050-1055. https://doi.org/10.4065/mcp.2011.0208
  80. Jaddou HY, Batieha AM, Khader YS, Kanaan SH, El- Khateeb MS, Ajlouni KM. 2012. Depression is associated with low levels of 25-hydroxyvitamin D among Jordanian adults: results from a national population survey. Eur Arch Psychiatry Clin Neurosci 262: 321-327. https://doi.org/10.1007/s00406-011-0265-8
  81. Kjærgaard M, Joakimsen R, Jorde R. 2011. Low serum 25- hydroxyvitamin D levels are associated with depression in an adult Norwegian population. Psychiatry Research 190: 221-225. https://doi.org/10.1016/j.psychres.2011.06.024
  82. Lee DM, Tajar A, O'Neill TW, O'Connor DB, Bartfai G, Boonen S, Bouillon R, Casanueva FF, Finn JD, Forti G, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Lean ME, Punab M, Silman AJ, Vanderschueren D, Wu FC, Pendleton N. 2011. Lower vitamin D levels are associated with depression among community-dwelling European men. J Psychopharmacol 25: 1320-1328. https://doi.org/10.1177/0269881110379287
  83. Hoogendijk WJ, Lips P, Dik MG, Deeg DJ, Beekman AT, Penninx BW. 2008. Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry 65: 508-512. https://doi.org/10.1001/archpsyc.65.5.508
  84. Cassidy-Bushrow AE, Peters RM, Johnson DA, Li J, Rao DS. 2012. Vitamin D nutritional status and antenatal depressive symptoms in African American women. J Womens Health (Larchmt) 21: 1189-1195. https://doi.org/10.1089/jwh.2012.3528
  85. Lapid MI, Cha SS, Takahashi PY. 2013. Vitamin D and depression in geriatric primary care patients. Clin Interv Aging 8: 509-514.
  86. Pan A, Lu L, Franco OH, Yu Z, Li H, Lin X. 2009. Association between depressive symptoms and 25-hydroxyvitamin D in middle-aged and elderly Chinese. J Affect Disord 118: 240-243. https://doi.org/10.1016/j.jad.2009.02.002
  87. Zhao G, Ford ES, Li C, Balluz LS. 2010. No associations between serum concentrations of 25-hydroxyvitamin D and parathyroid hormone and depression among US adults. Br J Nutr 104: 1696-1702. https://doi.org/10.1017/S0007114510002588
  88. Nanri A, Mizoue T, Matsushita Y, Poudel-Tandukar K, Sato M, Ohta M, Mishima N. 2009. Association between serum 25-hydroxyvitamin D and depressive symptoms in Japanese: analysis by survey season. Eur J Clin Nutr 63: 1444-1447. https://doi.org/10.1038/ejcn.2009.96
  89. Koo S, Park K. 2014. Associations of serum 25(OH)D levels with depression and depressed condition in Korean adults: results from KNHANES 2008-2010. J Nutr Health 47: 113-123. https://doi.org/10.4163/jnh.2014.47.2.113
  90. Eskandari F, Martinez PE, Torvik S, Phillips TM, Sternberg EM, Mistry S, Ronsaville D, Wesley R, Toomey C, Sebring NG, Reynolds JC, Blackman MR, Calis KA, Gold PW, Cizza G. 2007. Low bone mass in premenopausal women with depression. Arch Intern Med 167: 2329-2336. https://doi.org/10.1001/archinte.167.21.2329
  91. Chan R, Chan D, Woo J, Ohlsson C, Mellstrom D, Kwok T, Leung P. 2011. Association between serum 25-hydroxyvitamin D and psychological health in older Chinese men in a cohort study. J Affect Disord 130: 251-259. https://doi.org/10.1016/j.jad.2010.10.029
  92. Brouwer-Brolsma EM, Feskens EJ, Steegenga WT, de Groot LC. 2013. Associations of 25-hydroxyvitamin D with fasting glucose, fasting insulin, dementia and depression in European elderly: the SENECA study. Eur J Nutr 52: 917-925. https://doi.org/10.1007/s00394-012-0399-0
  93. Tolppanen AM, Sayers A, Fraser WD, William D, Lewis G, Zammit S, Lawlor DA. 2012. The association of serum 25-hydroxyvitamin $D_3$ and $D_2$ with depressive symptoms in childhood - a prospective cohort study. J Child Psychol Psychiatry 53: 757-766. https://doi.org/10.1111/j.1469-7610.2011.02518.x
  94. Jorde R, Sneve M, Figenschau Y, Svartberg J, Waterloo K. 2008. Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. J Intern Med 264: 599-609. https://doi.org/10.1111/j.1365-2796.2008.02008.x
  95. Kjaergaard M, Waterloo K, Wang CE, Almas B, Figenschau Y, Hutchinson MS, Svartberg J, Jorde R. 2012. Effect of vitamin D supplement on depression scores in people with low levels of serum 25-hydroxyvitamin D: nested case-control study and randomised clinical trial. Br J Psychiatry 201: 360-368. https://doi.org/10.1192/bjp.bp.111.104349
  96. Bertone-Johnson ER, Powers SI, Spangler L, Larson J, Michael YL, Millen AE, Bueche MN, Salmoirago-Blotcher E, Wassertheil-Smoller S, Brunner, Robert L, Ockene I, Ockene JK, Liu S, Manson JE. 2012. Vitamin D supplementation and depression in the women's health initiative calcium and vitamin D trial. Am J Epidemiol 176: 1-13. https://doi.org/10.1093/aje/kwr482
  97. Hogberg G, Gustafsson SA, Hällström T, Gustafsson T, Klawitter B, Petersson M. 2012. Depressed adolescents in a case-series were low in vitamin D and depression was ameliorated by vitamin D supplementation. Acta Paediatrica 101: 779-783. https://doi.org/10.1111/j.1651-2227.2012.02655.x
  98. Bertone-Johnson ER, Powers SI, Spangler L, Brunner RL, Michael YL, Larson JC, Millen AE, Bueche MN, Salmoirago- Blotcher E, Liu S, Wassertheil-Smoller S, Ockene JK, Ockene I, Manson JE. 2011. Vitamin D intake from foods and supplements and depressive symptoms in a diverse population of older women. Am J Clin Nutr 94: 1104-1112. https://doi.org/10.3945/ajcn.111.017384
  99. Anglin RE, Samaan Z, Walter SD, McDonald SD. 2013. Vitamin D deficiency and depression in adults: systematic review and meta-analysis. Br J Psychiatry 202: 100-107. https://doi.org/10.1192/bjp.bp.111.106666
  100. Ju SY, Lee YJ, Jeong SN. 2013. Serum 25-hydroxyvitamin D levels and the risk of depression: A systematic review and meta-analysis. J Nutr Health Aging 17: 447-455. https://doi.org/10.1007/s12603-012-0418-0
  101. Shinpo K, Kikuchi S, Sasaki H, Moriwaka F, Tashiro K. 2000. Effect of 1,25-dihydroxyvitamin $D_3$ on cultured mesencephalic dopaminergic neurons to the combined toxicity caused by L-buthionine sulfoximine and 1-methyl-4-phenyl pyridine. J Neurosci Res 62: 374-382. https://doi.org/10.1002/1097-4547(20001101)62:3<374::AID-JNR7>3.0.CO;2-7
  102. Jorde R, Waterloo K, Saleh F, Haug E, Svartberg J. 2006. Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels. The Tromsø study. J Neurol 253: 464-470. https://doi.org/10.1007/s00415-005-0027-5
  103. Brown J, Bianco JI, McGrath JJ, Eyles DW. 2003. 1,25- Dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci Lett 343: 139-143. https://doi.org/10.1016/S0304-3940(03)00303-3
  104. Newmark HL, Newmark J. 2007. Vitamin D and Parkinson's disease - a hypothesis. Mov Disord 22: 461-468. https://doi.org/10.1002/mds.21317
  105. Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D. 2002. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 13: 100-105. https://doi.org/10.1016/S1043-2760(01)00547-1
  106. Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, Andress DL. 2007. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71: 31-38. https://doi.org/10.1038/sj.ki.5002009
  107. Institute of Medicine. 2011. Dietary reference intakes for calcium and vitamin D. National Academies Press, Washington, DC, USA. p 12.
  108. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM. 2011. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96: 1911-1930. https://doi.org/10.1210/jc.2011-0385
  109. Peppone LJ, Huston AJ, Reid ME, Rosier RN, Zakharia Y, Trump DL, Mustian KM, Janelsins MC, Purnell JQ, Morrow GR. 2011. The effect of various vitamin D supplementation regimens in breast cancer patients. Breast Cancer Res Treat 127: 171-177. https://doi.org/10.1007/s10549-011-1415-4
  110. Pearce SH, Cheetham TD. 2010. Diagnosis and management of vitamin D deficiency. BMJ 340: b5664. https://doi.org/10.1136/bmj.b5664

Cited by

  1. Comparison of Physicochemical Properties and Antioxidant Activities between Lentinula edodes and New Cultivar Lentinula edodes GNA01 vol.44, pp.10, 2015, https://doi.org/10.3746/jkfn.2015.44.10.1484
  2. Food Habits, Dietary Intake, and Body Composition in Children with Cerebral Palsy vol.7, pp.4, 2018, https://doi.org/10.7762/cnr.2018.7.4.266
  3. 의료시설의 치유적 환경을 위한 자연광조명시스템에 관한 연구 vol.25, pp.6, 2014, https://doi.org/10.14774/jkiid.2016.25.6.139
  4. 한국 20대의 비타민 D 결핍 관련요인 분석 : 제 5기 국민건강영양조사를 이용하여 vol.19, pp.5, 2018, https://doi.org/10.5762/kais.2018.19.5.303